Isolation and characterisation of human monoclonal antibodies specific to antigens expressed in cancer
MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); ANTIKÖRPERTECHNIKEN (IMMUNOLOGISCHE TECHNIKEN); ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); THROMBOSPONDIN (PROTEINE UND PEPTIDE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); ANTIBODY TECHNIQUES (IMMUNOLOGICAL TECHNIQUES); TARGETED DRUGS (PHARMACOLOGY); THROMBOSPONDIN (PROTEINS AND PEPTIDES); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY), info:eu-repo/classification/ddc/610, Medical sciences, medicine
Networked Digital Library of Theses and Dissertations